Structure-activity relationships of flavonoids as potential inhibitors of glycogen phosphorylase

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 12, 2008, Pages 4469-4473

  Kato, Atsushi ^a   Nasu, Norio ^a   Takebayashi, Kenji ^a   Adachi, Isao ^a   Minami, Yasuhiro ^b   Sanae, Fujiko ^b   Asano, Naoki ^b   Watson, Alison A ^c   Nash, Robert J ^c  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c ABERYSTWYTH UNIVERSITY   (United Kingdom)

Author keywords

1,4 dideoxy 1,4 imino D arabinitol; Enzyme inhibitor; Flavonoids; Glycogen phosphorylase; Multiple inhibition study

Indexed keywords

ENZYME INHIBITOR; FLAVONOID; GLUCAGON; GLYCOGEN PHOSPHORYLASE; QUERCETIN;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GLYCOGENOLYSIS; LIVER CELL; MALE; RAT; STRUCTURE ACTIVITY RELATION; WISTAR RAT;

ANIMALS; CELLS, CULTURED; ENZYME INHIBITORS; FLAVONOIDS; GLUCAGON; GLYCOGEN PHOSPHORYLASE; GLYCOGENOLYSIS; HEPATOCYTES; MALE; QUERCETIN; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP;

RATTUS;

EID: 47349107198     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf800569s     Document Type: Article

References (26)

1. Harborne, J. B.; Williams, C. A. Advances in flavonoid research since 1992. Phytochemistry 2000, 55, 481-504.
2. Al-Awwadi, N.; Azay, J.; Poucheret, P.; Cassanas, G.; Krosniak, M.; Auger, C.; Gase, F.; Rouanet, J. M.; Cros, G.; Teissedre, P. L. Antidiabetic activity of red wine polyphenolic extract, ethanol, or both in streptozotocin-treated rats. J. Agric. Food Chem. 2004, 52, 1008-1016.
3. Vinson, J. A.; Zhang, J. Black and green teas equally inhibit diabetic cataracts in a streptozotocin-induced rat model of diabetes. J. Agric. Food Chem. 2005, 53, 3710-3713.
4. DeFronzo, R. A.; Bonadonna, R. C.; Ferrannini, E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992, 15, 318-68.
5. Cefalu, W. T. Insulin resistance: Cellular and clinical concepts. Exp. Biol. Med. 2001, 226, 13-26.
6. Diraison, F.; Large, V.; Brunengraber, H.; Beylot, M. Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM. Diabetologia 1998, 41, 212-220.
7. Lewis, G. F.; Carpentier, A.; Vranic, M.; Giacca, A. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes 1999, 48, 570-576.
8. Massillon, D.; Bollen, M.; De Wulf, H.; Overloop, K.; Vanstapel, F.; Van Hecke, P.; Stalmans, W. Demonstration of a glycogen/glucose 1-phosphate cycle in hepatocytes from fasted rats. Selective inactivation of phosphorylase by 2-deoxy-2-fluoro-alpha-D-glucopyranosyl fluoride. J. Biol. Chem. 1995, 270, 19351-19356.
9. Board, M.; Hadwen, M.; Johnson, L. N. Effects of novel analogues of D-glucose on glycogen phosphorylase activities in crude extracts of liver and skeletal muscle. Eur. J. Biochem. 1995, 228, 753-761.
10. Bichard, C. J. F.; Mitchell, E. P.; Wormald, M. R.; Watson, R. A.; Johnson, L. N.; Zographos, S. E.; Koutra, D. D.; Oikonomakos, N. G.; Fleet, G. W. J. Potent inhibition of glycogen phosphorylase by a spirohydantoin of glucopyranose: First pyranose analogs of hydantocidin. Tetrahedron Lett. 1995, 36, 2145-8.
11. Ercan-Fang, N.; Nuttall, F. Q. The effect of caffeine and caffeine analogs on rat liver phosphorylase a activity. J. Pharmacol. Exp. Ther. 1997, 280, 1312-1318.
12. Bergans, N.; Stalmans, W.; Goldmann, S.; Vanstapel, F. Molecular mode of inhibition of glycogenosis in rat liver by the dihydropyridine derivative, BAY R3401: Inhibition and inactivation of glycogen phosphorylase by an activated metabolite. Diabetes 2000, 49, 1419-1426.
13. Oikonomakos, N. G.; Skamnaki, V. T.; Tsitsanou, K. E.; Gavalas, N. G.; Johnson, L. N. A new allosteric site in glycogen phosphorylase b as a target for drug interactions. Structure 2000, 15, 575-584.
14. Rath, V. L.; Ammirati, M.; Danley, D. E.; Ekstrom, J. L.; Gibbs, E. M.; Hynes, T. R.; Mathiowetz, A. M.; McPherson, R. K.; Olson, T. V.; Treadway, J. L.; Hoover, D. J. Human liver glycogen phosphorylase inhibitors bind at a new allosteric site. Chem. Biol. 2000, 7, 677-682.
15. Fosgerau, K.; Westergaard, N.; Quistorff, B.; Grunnet, N.; Kristiansen, M.; Lundgren, K. Kinetic and functional characterization of 1,4-dideoxy-1,4- imino-D-arabinitol: A potent inhibitor of glycogen phosphorylase with anti-hyperglycemic effect in ob/ob mice. Arch. Biochem. Biophys. 2000, 380, 274-284.
16. Oikonomakos, N. G.; Tiraidis, C.; Leonidas, D. D.; Zographos, S. E.; Kristiansen, M.; Jessen, C. U.; Nørskov-Lauritsen, L.; Agius, L. Iminosugars as potential inhibitors of glycogenosis: Structural insights into the molecular basis of glycogen phosphorylase inhibition. J. Med. Chem. 2006, 49, 5687-5701.
17. Gasparin, F. R.; Spitzner, F. L.; Ishii-Iwamoto, E. L.; Bracht, A.; Constantin, J. Actions of quercetin on gluconeogenesis and glycolysis in rat liver. Xenobiotica. 2003, 33, 903-911.
18. Prince, P. S. M.; Kamalakkannan, N. Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. J. Biochem. Mol. Toxicol. 2006, 20, 96-102.
19. Fiske, C. H.; Subbarow, Y. The colorimetric determination of phosphorus. J. Biol. Chem. 1925, 66, 375-380.
20. Bissell, D. M.; Hammaker, L. E.; Meyer, U. A. Parenchymal cells from adult rat liver in nonproliferating monolayer culture. I. Functional studies. J. Cell Biol. 1973, 59, 722-734.
21. Andersen, B.; Westergaard, N. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors. Biochem. J. 2002, 367, 443-450.
22. Peluso, M. R. Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Exp. Biol. Med. 2006, 231, 1287-1299.
23. Winkel-Shirley, B. Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol. 2001, 126, 485-493.
24. Johnson, L. N. Glycogen phosphorylase: Control by phosphorylation and allosteric effectors. FASEB J. 1992, 6, 2274-2282.
25. Webb, J. L. In Enzyme and Metabolic Inhibitors; Academic Press: London, 1963; Vol. 0.1, pp 488-490.
26. McLean, J. E.; Neidhardt, E. A.; Grossman, T. H.; Hedstrom, L. Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate. Biochemistry 2001, 40, 2194-2200.